Investors

Webcast ImageWebcast - Live
Q1 2017 OraSure Technologies, Inc. Earnings Conference Call
05/03/17 at 5:00 p.m. ET
Q1 2017 OraSure Technologies, Inc. Earnings Conference Call
Wednesday, May 3, 2017 5:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2016 Annual Report on Form 10-K - PDF 2016 Annual Report on Form 10-K
Fact Sheet - PDF Fact Sheet
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$13.11
Change (%) Stock is Up 0.10 (0.69%)
Volume668,301
Data as of 04/28/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
04/12/17OraSure Technologies Earnings Conference Call Invitation
2017 First Quarter Earnings Conference Call Wednesday, May 3, 2017, 5:00 p.m. ET BETHLEHEM, Pa., April 12, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2017 First quarter financial results, 2017 second quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 3, 2017.      May 3, 2017 Schedule       4:00... 
Printer Friendly Version
03/01/17OraSure Receives Global Fund Classification to Enable HIV Self-Test Procurement
BETHLEHEM, Pa., March 01, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that its OraQuick® HIV Self-Test has been designated as eligible for procurement by purchasing entities entitled to access Global Fund and/or UNITAID resources.  The OraQuick® HIV Self-Test has been classified by the Global Fund’s Expert Review Panel for Diagnostics as CATEGORY-2. The classification facilitates... 
Printer Friendly Version
02/27/17OraSure Technologies to Present at the Raymond James 38th Annual Institutional Investors Conference
BETHLEHEM, Pa., Feb. 27, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Raymond James 38th Annual Institutional Investors Conference in Orlando, Florida.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on March 6, 2017, at approximately 8:40... 
Printer Friendly Version
02/24/17OraSure Technologies Announces Director Retirement
BETHLEHEM, Pa., Feb. 24, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Roger L. Pringle will be retiring as a member of the Company’s Board of Directors, effective May 16, 2017.  Mr. Pringle is the Company’s longest tenured Director, having served on the Board since September 2000.  Prior to that, Mr. Pringle served as Chairman of the Board and Director of one of the Company’s ... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
05/03/17 5:00 p.m. ET
Q1 2017 OraSure Technologies, Inc. Earnings Conference Call
05/16/17 10:00 a.m. ET
OraSure Technologies, Inc. 2017 Annual Meeting of Stockholders
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet